h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
CSUASOi001-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
CSUASOi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
CSUASOi001-A (RRID:CVCL_WU16)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
18th March 2019
User feedback
show/hide
Written by Xin Yan on 2019-05-22 15:03:21
Delete
clear identification.
Written by
on
Delete
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Aier School of Ophthalmology (CSUASO)
External Databases
Cellosaurus
CVCL_WU16
Wikidata
Q93459756
General Information
Publications
Yan X et al. Establishment of CSUASOi001-A, a non-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutation. Stem cell research. 2019 Jul;38:101466.
Gautam S et al. Urine Cells-derived iPSCs: An Upcoming Frontier in Regenerative Medicine. Current medicinal chemistry. 2021;28(31):6484-6505.
Cao Shuo et al. Derivation and characteristics of induced pluripotent stem cells from a patient with acute myelitis. Frontiers in Cell and Developmental Biology. 2023-07-14.
Liang Yuqin et al. Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases. Stem Cell Research & Therapy. 2023-11-27.
Mao S et al. Generation of a gene-corrected isogenic iPSC cell line from an X-linked retinoschisis patient with a hemizygous mutation c.304C > T (p.R102W) in RS1 gene. Stem cell research. 2023 Dec;73:103263.
Yin X et al. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing. Journal of biomedical science. 2024 May 9;31(1):47.
Sun X et al. Introduction of an RS1 mutation causative variant consistent with identified XLRS patient using CRISPR/Cas9 technology in normal iPSC. Stem cell research. 2024 Sep 1;81:103549.
Yang HS et al. Application prospects of urine-derived stem cells in neurological and musculoskeletal diseases. World journal of orthopedics. 2024 Oct 18;15(10):918-931.
Subclones
CSUASOi001-A-1
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.